ResourcesVendorsMolecular DiagnosticsQiagen19300 Germantown Road Germantown, MD, USA 20874Latest from QiagenPCRQiagen launches clinical oncology testing systemBy LabPulse.com staff writersQiagen has expanded its digital polymerase chain reaction portfolio and plans to enter the clinical testing space in North America and the European Union.October 1, 2024Microarrays and multiplexingQiagen ventures into chronic disease CDxBy LabPulse.com staff writersQiagen has expanded its agreement with AstraZeneca beyond oncology.August 29, 2024CollaborationMyriad Genetics, GSK team up for global ovarian cancer testingBy LabPulse.com staff writersGenetic testing and precision medicine company Myriad Genetics is collaborating with GSK to improve access to homologous recombination deficiency diagnostic testing for high-grade serous ovarian cancer patients in nine countries.June 11, 2024CollaborationQiagen, Myriad Genetics to develop HRD testBy LabPulse.com staff writersAs part of their recently announced collaboration, Qiagen and Myriad Genetics will develop a kit-based test for analyzing homologous recombination deficiency (HRD) status.June 5, 2024FDA ClearanceQiagen gets FDA clearance for respiratory syndromic testing panelBy LabPulse.com staff writersQiagen announced that it has received U.S. Food and Drug Administration (FDA) clearance for its QIAstat-Dx respiratory syndromic testing panel for clinical use.May 14, 2024PCRQiagen partners with FBI on forensics assayBy LabPulse.com staff writersQiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.May 8, 2024CollaborationQiagen, Myriad Genetics to collaborate on cancer companion diagnosticsBy LabPulse.com staff writersQiagen and Myriad Genetics have formed a new master collaboration agreement on the development of companion diagnostic tests for cancer.October 27, 2023LawsuitTecan Genomics files patent infringement lawsuits against Qiagen, Invitae, othersBy LabPulse.com staff writersTecan Genomics has filed two separate lawsuits claiming patent infringement -- the first against Invitae, its subsidiary ArcherDx, and IDT (a subsidiary of Danaher); the second against Qiagen.October 12, 2023Research GrantActome outlines sequencing expansion plans as EU funding kicks inBy Nick Paul TaylorActome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”September 7, 2023SequencingFBI approves Qiagen NGS workflow for the U.S. National DNA Index SystemBy LabPulse.com staff writersThe standardized workflow supports volume casework and sexual assault cases and is a cost-effective alternative to analyzing short tandem repeats with capillary electrophoresis, Qiagen said.June 20, 2023TuberculosisQiagen describes systematic review for IGRA TB test, blood collection tubesBy Leo O'ConnorThe study including 4,050 subjects highlights the value of the TB2 tube and the detection of CD8 T-cell responses for immunocompromised patients, a key risk group for tuberculosis disease, the firm said.June 15, 2023SequencingDanish National Genome Center selects Qiagen software for variant interpretationBy LabPulse.com staff writersThe initiative is part of a larger personalized medicine strategy that aims to provide whole-genome sequencing as a standard-of-care for relevant patient groups in Denmark.June 14, 2023Business InsightsWeek in Review: FDA approves RSV vaccine | Non-respiratory revenue rising | Latent TB screeningBy Leo O'ConnorRecommendations by the U.S. Preventive Services Task Force may benefit Qiagen and other makers of tests for latent TB.May 4, 2023Financial ResultsQiagen Q1 net sales decline 23% on COVID headwinds; non-COVID sales riseBy Leo O'ConnorNon-COVID product group sales rose due to underlying double-digit growth at constant exchange rates in consumables and related revenues.May 4, 2023Molecular DiagnosticsQiagen launching syndromic molecular diagnostic system with respiratory panel in JapanBy LabPulse.com staff writersQiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.April 24, 2023
